Table 3.
Prevalence of liver fibrosis by APRI and FIB-4 scores among HIV monoinfected and HIV/HBV coinfected patients.
All patients (n = 456) | HIV monoinfected (n = 427) | HBV/HIV (n = 29) | OR (95% CI) | P value | ||
---|---|---|---|---|---|---|
APRI score | 0.29 (0.19–0.44) | 0.28 (0.19–0.43) | 0.45 (0.23–0.85) | 2.21 (1.44–3.38) | <0.001 | |
APRI > 1.5 | 16 (3.51) | 11 (2.58) | 5 (17.24) | 7.88 (2.53–24.49) | <0.001 | |
APRI > 2.0 | 10 (2.19) | 6 (1.41) | 4 (13.79) | 22.1 (4.7–104.1) | <0.001 | |
FIB-4 score | 0.97 (0.65–1.54) | 0.96 (0.65–1.50) | 1.34 (0.82–2.09) | 1.24 (1.01–1.51) | 0.04 | |
FIB-4 > 3.25 | 21 (4.61) | 19 (4.49) | 2 (6.90) | 1.59 (0.35–7.18) | 0.55 |